Waxman And Hatch Foresee Follow-on Biologics Bill Regaining Momentum – In 2009

Closing window for congressional action, lack of House consensus and Sen. Kennedy’s absence among reasons the issue will be held until next year, they suggest.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet